A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepines
- 1 January 1983
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 7 (4-6), 629-635
- https://doi.org/10.1016/0278-5846(83)90036-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Time Course of Antirecall Effect of Diazepam and Lorazepam following Oral AdministrationAnesthesiology, 1981
- Simultaneous pharmacokinetic and pharmacodynamic modelingJournal of Pharmacokinetics and Biopharmaceutics, 1981
- LorazepamDrugs, 1981
- Cerebral Circulatory and Metabolic Responses to Intravenously Administered LorazepamAnesthesiology, 1980
- Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in HumansJournal of Pharmaceutical Sciences, 1979
- Clinical Pharmacokinetics of DiazepamClinical Pharmacokinetics, 1978
- Clinical Pharmacokinetics of Lorazepam. III. Intravenous Injection. Preliminary ResultsThe Journal of Clinical Pharmacology, 1977
- Pharmacokinetic Profile of Diazepam in Man following Single Intravenous and Oral and Chronic Oral AdministrationsJournal of Pharmaceutical Sciences, 1973
- Section C Lorazepam as a premedicant for general anaesthesiaCurrent Medical Research and Opinion, 1973
- Kinetics of pharmacologic response I. Proposed relationships between response and drug concentration in the intact animal and manJournal of Theoretical Biology, 1968